clinical trials

ACTIVE TRIALS

ACTIV-6

ACTIV-6 is evaluating repurposed medications for effective, safe treatments for mild-to-moderate COVID-19.  Repurposed medications are already approved by the U.S. Food and Drug Administration for other indications.  For more information, click on the link below.

https://activ6study.org/

2019nCoV406 (Novavax)

The primary objective of the study is to estimate the difference in percentage of participants with overall work impairment after the second dose of NVX-CoV2373 versus the second dose of an mRNA COVID-19 vaccine, regardless of which vaccine was used for the first dose or prior COVID-19 disease status, during the 6-day post-vaccination period.

Respiratory Swab Trial

Collection of nasal swab specimens for testing with an investigational device for COVID, Influenza, and RSV.

UPCOMING TRIALS

Hypertriglyceridemia

More information to follow.

COPD Trial

More information to follow.

COMPLETED TRIALS

STI-CLIN-007 (COVISTIX™)

COVISTIX™ is a rapid antigen test used to detect the COVID-19 virus from a nasal sample.   This research study was designed to compare results from the COVISTIX™ test to the results of a recent (<48 hours) COVID-19 RT-PCR test.

ACTIV-4b

The overall purpose of this study was to determine if commonly used antithrombotic strategies could be used to prevent thrombosis in COVID-19- positive outpatients by comparing the effectiveness of anticoagulation with antiplatelet agents and with placebo to prevent thrombotic events in stable, non-hospitalized patients diagnosed with COVID-19.

SPONSORS FORM

INVESTIGATORS FORM

Hello from Activian Clinical Research! We are excited about your interest in participating in research studies with us. To get started, we need to know about your site and its experiences. Please Answer All questions to the best of your ability. Once submitted, someone from Activian Clinical Research team will be reaching out to you.

PARTICIPANTS FORM